According to Novavax's latest financial reports the company's current EPS (TTM) is -$11.18. In 2022 the company made an earnings per share (EPS) of -$12.91 an increase over its 2021 EPS that were of -$36.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$10.75 | -16.74% |
2022 | -$12.91 | -64.36% |
2021 | -$36.22 | 243% |
2020 | -$10.56 | 19.75% |
2019 | -$8.82 | -43.86% |
2018 | -$15.71 | -19.84% |
2017 | -$19.59 | -38.83% |
2016 | -$32.04 | 74.58% |
2015 | -$18.35 | 63.89% |
2014 | -$11.20 | 16.13% |
2013 | -$9.64 | 40.91% |
2012 | -$6.84 | 29.41% |
2011 | -$5.29 | -50% |
2010 | -$10.57 | -27.66% |
2009 | -$14.62 | -11.32% |
2008 | -$16.48 | -7.02% |
2007 | -$17.73 | 46.15% |
2006 | -$12.13 | 50% |
2005 | -$8.09 | -63.38% |
2004 | -$22.08 | 20.34% |
2003 | -$18.35 | -35.87% |
2002 | -$28.61 | 113.95% |
2001 | -$13.37 | -33.85% |
2000 | -$20.22 | 109.68% |
1999 | -$9.64 | -40.38% |
1998 | -$16.17 | 30% |
1997 | -$12.44 | -9.007199254741E+17% |
1996 | $0.0000000000 |